Neurodegeneration
Can a 3D MRI network spot and forecast Parkinson’s?
Open access · cc by · source: Europe PMC
A 3D CNN using T1 MRI separated moderate-to-severe Parkinson’s disease from controls at 74% accuracy; transfer learning reached 64% for mild PD, and MRI plus clinical data predicted 2-year progression at >70%.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
The mild-disease figure is the one that matters for early diagnosis, and it is the weakest.
Machine learning on structural MRI reaches mid-range accuracy that improves with clinical data. MRI alone classified moderate-to-severe Parkinson's against controls at 74%, transfer learning raised mild Parkinson's against controls to 64%, and progression prediction exceeded 70% with MRI plus clinical features.
Evidence for the claim as stated.
How close any of these markers is to clinical use differs by orders of magnitude, and the authors disagree with the framing more than with each other. Tau PET separates two diseases at 94.1% in a selected sample, while the Parkinson's model's mid-70s accuracy is explicitly not a standalone diagnostic test, and the glymphatic ALPS index is a diffusion proxy not shown to equal cerebrospinal fluid clearance.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
How close any of these markers is to clinical use differs by orders of magnitude, and the authors disagree with the framing more than with each other. Tau PET separates two diseases at 94.1% in a selected sample, while the Parkinson's model's mid-70s accuracy is explicitly not a standalone diagnostic test, and the glymphatic ALPS index is a diffusion proxy not shown to equal cerebrospinal fluid clearance.
Study at a glance
- Design
- Computational / modelling — Multi-cohort 3D CNN on T1-weighted MRI (± clinical data) with transfer learning and k-means progression clusters
- N
- N=312 · Main: 86 mild PD, 62 moderate-to-severe PD, 60 controls; PPMI 14+14; de novo 38+38 (312 MRI/clinical participants)
- Population
- People with Parkinson’s disease (mild, moderate-to-severe, de novo) and controls from three cohorts including PPMI
- Outcome
- CNN accuracy for PD vs controls and for faster vs slower motor progression over ~2 years
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
Can a 3D MRI network spot and forecast Parkinson’s?
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
86 mild, 62 moderate-to-severe PD, 60 controls in the main cohort.
Three cohorts were selected: 86 mild, 62 moderate-to-severe PD patients, and 60 controls; 14 mild-PD patients and 14 controls from Parkinson's Progression Markers Initiative database, and 38 de novo mild-PD patients and 38 controls.
74% accuracy moderate-to-severe PD vs controls on MRI.
CNN effectively differentiated moderate-to-severe PD from controls (74% accuracy) using MRI data alone.
Key findings
MRI alone: 74% accuracy for moderate-to-severe PD vs controls. Transfer learning improved mild-PD vs control classification to 64%. Progression prediction exceeded 70% with MRI plus clinical features. Activation maps highlighted influential brain regions.
Methodology
Trained a 3D CNN on three cohorts (86 mild, 62 moderate-to-severe PD, 60 controls; PPMI 14+14; de novo 38+38), clustered PD motor progression with k-means on baseline/follow-up UPDRS-III, and tested transfer learning plus MRI+clinical fusion.
Limitations
Mid-70s accuracy is not a standalone diagnostic test; UPDRS-based clusters and multi-centre MRI do not replace clinical exam or prove who will need a specific treatment.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- How tau buildup shapes brain networks in dementia
- How does brain structure change in early Parkinson's disease?
- How does brain inflammation affect connectivity and thinking in AD?
- Can a new PET imaging tracer distinguish different tau diseases?
- Does brain region loss predict memory decline in Parkinson's?